Efficacy of Metreleptin in Obese Patients With Type 2 Diabetes: Cellular and Molecular Pathways Underlying Leptin Tolerance
Diabetes - United States
doi 10.2337/db10-1791
Full Text
Open PDFAbstract
Available in full text
Date
May 26, 2011
Authors
Publisher
American Diabetes Association